180 related articles for article (PubMed ID: 32023763)
1. [Clinical practice guideline for stage Ⅳ primary lung cancer in China(2020 version)].
Chinese Association for Clinical Oncologists
Zhonghua Zhong Liu Za Zhi; 2020 Jan; 42(1):1-16. PubMed ID: 32023763
[TBL] [Abstract][Full Text] [Related]
2. [Clinical practice guideline for stage Ⅳ primary lung cancer in China(2021 version)].
;
Zhonghua Zhong Liu Za Zhi; 2021 Jan; 43(1):39-59. PubMed ID: 33472316
[TBL] [Abstract][Full Text] [Related]
3. [Clinical practice guideline for stage Ⅳ primary lung cancer in China (2023 edition)].
;
Zhonghua Zhong Liu Za Zhi; 2023 Jan; 45(1):1-30. PubMed ID: 36709116
[TBL] [Abstract][Full Text] [Related]
4. [Clinical practice guideline for brain metastases of lung cancer in China (2021 version)].
;
Zhonghua Zhong Liu Za Zhi; 2021 Mar; 43(3):269-281. PubMed ID: 33752305
[TBL] [Abstract][Full Text] [Related]
5. [Clinical practice guideline for multi-disciplinary team diagnosis and treatment of stage Ⅳ primary lung cancer in China].
;
Zhonghua Zhong Liu Za Zhi; 2022 Jul; 44(7):667-672. PubMed ID: 35880332
[TBL] [Abstract][Full Text] [Related]
6. New Developments in Neoadjuvant Therapy for Lung Cancer.
Bunn PA; Schenk E; Pacheco J; Dimou A
Oncology (Williston Park); 2019 Mar; 33(3):101-6, 109. PubMed ID: 30866032
[TBL] [Abstract][Full Text] [Related]
7. [Clinical practice guideline for lympoma in China (2021 Edition)].
; ;
Zhonghua Zhong Liu Za Zhi; 2021 Jul; 43(7):707-735. PubMed ID: 34289565
[TBL] [Abstract][Full Text] [Related]
8. [Chinese expert consensus on the multidisciplinary clinical diagnosis and treatment of stage Ⅲ non-small cell lung cancer (2019)].
;
Zhonghua Zhong Liu Za Zhi; 2019 Dec; 41(12):881-890. PubMed ID: 31874543
[TBL] [Abstract][Full Text] [Related]
9. [Oncology Society of Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2021 edition)].
;
Zhonghua Zhong Liu Za Zhi; 2021 Jun; 43(6):591-621. PubMed ID: 34289551
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy of lung cancer: an update.
Rüttinger D; Winter H; van den Engel NK; Hatz RA; Schlemmer M; Pohla H; Grützner S; Schendel DJ; Fox BA; Jauch KW
Onkologie; 2006 Feb; 29(1-2):33-8. PubMed ID: 16514254
[TBL] [Abstract][Full Text] [Related]
11. [Chinese Medical Association guidelines for clinical diagnosis and treatment of lung cancer (2019 edition)].
; ;
Zhonghua Zhong Liu Za Zhi; 2020 Apr; 42(4):257-287. PubMed ID: 32375445
[TBL] [Abstract][Full Text] [Related]
12. [Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2022 edition)].
;
Zhonghua Zhong Liu Za Zhi; 2022 Jun; 44(6):457-490. PubMed ID: 35754224
[TBL] [Abstract][Full Text] [Related]
13. Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy.
Osmani L; Askin F; Gabrielson E; Li QK
Semin Cancer Biol; 2018 Oct; 52(Pt 1):103-109. PubMed ID: 29183778
[TBL] [Abstract][Full Text] [Related]
14. Evaluating lung cancer screening in China: Implications for eligibility criteria design from a microsimulation modeling approach.
Sheehan DF; Criss SD; Gazelle GS; Pandharipande PV; Kong CY
PLoS One; 2017; 12(3):e0173119. PubMed ID: 28273181
[TBL] [Abstract][Full Text] [Related]
15. [Looking back 2018--focused on colorectal cancer].
Cai J; Wang L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):9-16. PubMed ID: 30703787
[TBL] [Abstract][Full Text] [Related]
16. A multicenter survey of first-line treatment patterns and gene aberration test status of patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer in China (CTONG 1506).
Zhou Q; Song Y; Zhang X; Chen GY; Zhong DS; Yu Z; Yu P; Zhang YP; Chen JH; Hu Y; Feng GS; Song X; Shi Q; Yang LL; Zhang PH; Wu YL
BMC Cancer; 2017 Jul; 17(1):462. PubMed ID: 28673332
[TBL] [Abstract][Full Text] [Related]
17. [Guidelines for clinical diagnosis and treatment of advanced breast cancer in China (2020 Edition)].
; ;
Zhonghua Zhong Liu Za Zhi; 2020 Oct; 42(10):781-797. PubMed ID: 33113619
[TBL] [Abstract][Full Text] [Related]
18. Targeted Therapy and Immunotherapy for Lung Cancer.
Naylor EC; Desani JK; Chung PK
Surg Oncol Clin N Am; 2016 Jul; 25(3):601-9. PubMed ID: 27261918
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
[TBL] [Abstract][Full Text] [Related]
20. [National Clinical Practice Guidelines for the management of non-small cell lung cancer in early, locally advanced and metastatic stages. Extended version].
Barrón-Barrón F; Guzmán-De Alba E; Alatorre-Alexander J; Aldaco-Sarvider F; Bautista-Aragón Y; Blake-Cerda M; Blanco-Vázquez YC; Campos-Gómez S; Corona-Cruz JF; Iñiguez-García MA; Lozano-Ruiz FJ; Maldonado-Magos F; de la Mata-Moya D; Martínez-Barrera LM; Ramos-Prudencio R; Rodríguez-Cid J; Rivera-Rivera S; Trejo-Rosales RR; Aguilar-Ortíz MR; Astudillo-de la Vega H; Barajas-Figueroa LJ; Barroso-Quiroga N; Blanco-Salazar A; Castillo-Ortega G; Domínguez-Parra LM; Enriquez-Aceves MI; Fernández-Orozco A; Figueroa-Morales MA; Green-Schneewiss L; González-Garay JA; González Ramírez-Benfield R; Guadarrama-Orozco A; Guerrero-Ixtlahuac J; Hernández-Barajas D; Hernández-Montes de Oca R; Kelly-García J; Lázaro-León M; Silva-Bravo F; Tellez-Becerra JL; Macedo-Pérez EO; Maza-Ramos G; Mayorga-Butrón JL; Montaño-Velázquez BB; Murillo-Medina K; Narváez-Fernández S; Ochoa-Carrillo FJ; Olivares-Beltrán G; Olivares-Torres C; Ponce de León-Castillo M; Ponce-Viveros MA; Rubio-Gutiérrez JE; Sáenz-Frías JA; Silva-Vivas JA; Santillán-Doherty P; Soto-Ávila JJ; Toledo-Buenrostro V; Vargas-Abrego B; Velasco-Hidalgo L; Zapata-Tarres MM; Quintero-Beuló G; Arrieta O
Salud Publica Mex; 2019; 61(3):359-414. PubMed ID: 31276353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
